Case Study: Supporting Global Delivery of a Phase III Cardiovascular Outcomes Trial for a Global Top-10 Pharmaceutical Company
Executing a Complex Phase III Diabetes Cardiovascular Outcomes Trial in a High-Risk Population Cardiovascular outcomes trials (CVOTs) in type 2 diabetes present a unique combination of clinical, operational, and regulatory complexity, particularl...
